Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
Clinical trial NCT01820260 · COMPLETED
Trial details
- NCT number
- NCT01820260
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.